Cargando…

Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema

PURPOSE: To examine the comorbidity profile and update estimates of health care resource utilization for commercially insured, working-age adults with diabetic macular edema (DME) relative to a matched comparison group of diabetic adults without DME. Additional comparisons were made in the subgroup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiss, Szilárd, Chandwani, Hitesh S, Cole, Ashley L, Patel, Vaishali D, Lunacsek, Orsolya E, Dugel, Pravin U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153291/ https://www.ncbi.nlm.nih.gov/pubmed/27994438 http://dx.doi.org/10.2147/OPTH.S114006

Ejemplares similares

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA
por: Chakravarthy, Usha, et al.
Publicado: (2018)

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data
por: Dugel, Pravin U., et al.
Publicado: (2019)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper, J Michael, et al.
Publicado: (2018)

Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review
por: Sheu, Shwu-Jiuan, et al.
Publicado: (2018)

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema
por: Dugel, Pravin U., et al.
Publicado: (2021)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
por: Blinder, Kevin J, et al.
Publicado: (2017)

Bilateral cytomegalovirus retinitis comorbid with diabetic macular edema
por: Chao, Yu-Jang, et al.
Publicado: (2019)

Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Kiss, Szilárd, et al.
Publicado: (2020)

Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema
por: Khanani, Arshad M., et al.
Publicado: (2021)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
por: Dugel, Pravin U, et al.
Publicado: (2016)

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data
por: Sadda, Srinivas R., et al.
Publicado: (2019)

Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
por: Gonder, John R., et al.
Publicado: (2014)

Postpartum care visits among commercially insured women in the United States
por: Butwick, Alexander J., et al.
Publicado: (2022)

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
por: Kiss, Szilárd, et al.
Publicado: (2018)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa
por: Mannie, Cristina, et al.
Publicado: (2020)

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
por: Kiss, Szilárd, et al.
Publicado: (2014)

Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study
por: Singer, Michael A, et al.
Publicado: (2015)

Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study
por: Dugel, Pravin U., et al.
Publicado: (2015)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema
por: Gelfman, Claire M., et al.
Publicado: (2021)

Real-world treatment patterns and economic burden of post-cataract macular edema
por: Ahmadyar, Gina, et al.
Publicado: (2023)

Cystoid macular edema
por: Rotsos, Tryfon G, et al.
Publicado: (2008)

Diabetic Macular Edema
por: Gundogan, Fatih C., et al.
Publicado: (2016)

Mechanisms of macular edema
por: Haydinger, Cameron D., et al.
Publicado: (2023)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Analysis of a Commercial Insurance Policy to Deny Coverage for Emergency Department Visits With Nonemergent Diagnoses
por: Chou, Shih-Chuan, et al.
Publicado: (2018)

Measuring the geographic disparity of comorbidity in commercially insured individuals compared to the distribution of physicians in South Africa
por: Mannie, Cristina, et al.
Publicado: (2022)

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
por: Zakaria, Nadia, et al.
Publicado: (2022)

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis
por: Souied, Eric H., et al.
Publicado: (2016)

Trends in rotator cuff repair rates and comorbidity burden among commercially insured patients younger than the age of 65 years, United States 2007-2016
por: Yanik, Elizabeth L., et al.
Publicado: (2021)

Refractory Diabetic Macular Edema
por: Bainbridge, James
Publicado: (2010)

Macular edema in siliconized eyes
por: Kaya, Abdullah, et al.
Publicado: (2016)

Macular Edema after Gabapentin
por: Kim, Ju Young, et al.
Publicado: (2016)

Macular Edema: Drying Is Not Repairing
por: Tadayoni, Ramin
Publicado: (2013)

Corticosteroids for Diabetic Macular Edema
por: Chawan-Saad, Jorge, et al.
Publicado: (2019)

The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden
por: Nuutinen, Mikko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6uf5324jcl5v405gu2c8i5p5r4